Vitae Pharmaceuticals, Inc
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|
| Revenue | $150,000 | $1.2M | $22.5M | $22.3M |
| Operating income | −$44.3M | −$18.5M | $2.2M | $1.5M |
| Net income | −$9.7M | −$4.9M | $1.2M | $223,086 |
| Total assets | $61.8M | $67.7M | $34.0M | — |
| Total liabilities | $7.4M | $8.9M | $15.1M | — |
| Equity | $54.5M | $58.7M | −$106.9M | −$108.2M |
| EPS (diluted) | $-2.03 | $-3.61 | $0.00 | $0.00 |
| Shares out. | 21.8M | 18.0M | 588,733 | 542,320 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- −29526.7%
- Net margin
- −6471.3%
- Return on equity
- −17.8%
- Return on assets
- −15.7%
- Return on capital (ROCE)
- −81.2%
- Liabilities / assets
- 11.9%
- Debt / equity
- 0.14×
- Book value / share
- $2.50
- Revenue growth (YoY)
- −87.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- -0.52distress
- Accruals / assets
- 45.8%high accruals
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsOct 25, 2016
- Entered a material agreementSep 14, 2016
- Results of operations · Regulation FD disclosureAug 3, 2016
- Director / officer changeJul 27, 2016
- Entered a material agreementJun 30, 2016
- Shareholder voteMay 26, 2016
- Results of operationsMay 10, 2016
- Entered a material agreement · Other material eventMar 24, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.